Author

N. Roper

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:proteomics· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

A. Thomas· 2 shared A. Venugopalan· 2 shared C. M. Cultraro· 2 shared R. Biswas· 2 shared S. Gao· 2 shared T. K. Maity· 2 shared U. Guha· 2 shared X. Zhang· 2 shared

Activity by Year

2018-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Thomas

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

SCLC_CellMiner: Integrated Genomics and Therapeutics Predictors of Small Cell Lung Cancer Cell Lines based on their genomic signatures

C. Tlemsani, L. Pongor, L. Girard, N. Roper, F. Elloumi, S. Varma, A. Luna, V. N. Rajapakse, R. Sebastian, K. W. Kohn, J. Krushkal, M. Aladjem, B. Teicher, P. S. Meltzer, W. C. Reinhold, , Y. Pommier

SCLC_CellMiner provides an integrated resource of 118 SCLC cell lines with omics data and drug sensitivity, identifying molecular subtypes and therapeutic targets.

bioRxiv · Mar 9, 2020 · PreprintCancer Biology

Quantitative mass spectrometry to interrogate proteomic heterogeneity in metastatic lung adenocarcinoma and validate a novel somatic mutation CDK12-G879V

X. Zhang, K. D. Nguyen, P. Rudnick, N. Roper, E. Kawaler, T. K. Maity, S. Awasthi, S. Gao, R. Biswas, A. Venugopalan, C. M. Cultraro, D. Fenyo, U. Guha

The paper uses quantitative mass spectrometry to analyze proteomic and phosphoproteomic changes in metastatic lung adenocarcinoma and validates a novel somatic mutation CDK12-G879V associated with chemotherapy sensitivity.

bioRxiv · Aug 22, 2018Cancer Biology

Integrated proteogenomic analysis of metastatic thoracic tumors identifies APOBEC mutagenesis and copy number alterations as drivers of proteogenomic tumor evolution and heterogeneity

N. Roper, S. Gao, T. K. Maity, A. R. Banday, X. Zhang, A. Venugopalan, C. M. Cultraro, R. Patidar, S. Sindiri, A. Goncearenco, A. R. Panchenko, R. Biswas, A. Thomas, A. Rajan, C. A. Carter, , U. Guha

bioRxiv · May 11, 2018Cancer Biology